Roche Holding AG
SIX:ROG
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
214.1
287.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Roche Holding AG
Roche Holding AG
Current Portion of Long-Term Debt
Roche Holding AG
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Current Portion of Long-Term Debt
CHf3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Novartis AG
SIX:NOVN
|
Current Portion of Long-Term Debt
$8.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Current Portion of Long-Term Debt
$323m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Roche Holding AG
Glance View
Roche Holding AG, a Swiss multinational healthcare company, has carved a prominent niche in the pharmaceutical and diagnostics markets since its founding in 1896. The company is powered by a strong commitment to innovation, investing heavily in research and development to bring cutting-edge treatments to patients around the world. Roche is particularly well-regarded for its pioneering work in oncology, with several blockbuster cancer medications, such as Herceptin and Avastin, which have significantly improved patient outcomes. Beyond drugs, Roche's diagnostics division is a leader in developing diagnostic tests and equipment, playing a crucial role in early disease detection and management. This dual approach—pharmaceuticals and diagnostics—positions Roche uniquely in the healthcare ecosystem, allowing for a comprehensive understanding of patient needs. For investors, Roche offers a compelling value proposition characterized by robust financial performance and a strong pipeline of new treatments poised for market entry. The company's solid historical growth, substantial dividend returns, and strategic acquisitions illustrate its disciplined approach to capital allocation. Despite challenges such as regulatory pressures and market competition, Roche's strong balance sheet, global footprint, and emphasis on personalized medicine enhance its resilience and potential for sustainable growth. With an eye firmly fixed on the future, Roche continues to explore breakthrough therapies and technologies that could change the landscape of healthcare, making it an intriguing choice for investors seeking stability alongside the promise of innovation.
See Also
What is Roche Holding AG's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
3B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Current Portion of Long-Term Debt amounts to 3B CHF.
What is Roche Holding AG's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
3%
Over the last year, the Current Portion of Long-Term Debt growth was 70%. The average annual Current Portion of Long-Term Debt growth rates for Roche Holding AG have been 18% over the past three years , 9% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
